Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zerbaxa
Marketing
Merck touts latest results for antibiotic Recarbrio
Merck's antibiotic Recarbrio won its first FDA nod in July. Now, thanks to new trial results in severe pneumonia, it's eyeing another approval.
Eric Sagonowsky
Oct 1, 2019 9:20am
Merck wins nod for Recarbrio, a resistance-fighting combo drug
Jul 17, 2019 12:34pm
Merck scores new Zerbaxa use years after Cubist buyout
Jun 3, 2019 5:04pm
